Home

Promoting
immune tolerance,
ameliorating disease

Transforming
Treatment in Autoimmune Disease

Anokion is an innovative immune tolerance company focused on providing a more effective approach to treating autoimmune disease. Our proprietary immune tolerance platform features proteins, or antigens, that are engineered to deliver precise, targeted disease therapy, without the side effects of broad immunosuppression. Anokion’s antigen-specific platform can be translated to virtually any antigen-mediated disease, with widespread potential across multiple clinical applications.

Find Out More

News

Join
our team

Careers